SS
MRNA icon

SBI Securities’s Moderna MRNA Stock Holding History

SBI Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Sell
16,425
-370
-2% -$19.1K 0.03% 266
2026
Q1 		$853K Sell
16,795
-1,458
-8% -$68K 0.02% 298
2025
Q4 		$538K Sell
18,253
-5,657
-24% -$154K 0.01% 386
2025
Q3 		$618K Buy
23,910
+2,211
+10% +$61.7K 0.02% 349
2025
Q2 		$599K Buy
21,699
+2,138
+11% +$56.3K 0.02% 337
2025
Q1 		$555K Buy
19,561
+1,502
+8% +$53.3K 0.02% 328
2024
Q4 		$751K Buy
+18,059
New +$863K 0.02% 289

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

SBI Securities's MRNA Position: Q2 2026 in Review

SBI Securities reduced its Moderna (MRNA) stake by 2.2% in Q2 2026, selling an estimated $19.1K and leaving 16,425 shares worth $1.15M. The position accounts for 0.03% of the portfolio, ranked #266.

SBI Securities first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • SBI Securities held 16,425 shares of Moderna worth $1.15M as of Q2 2026.
  • SBI Securities sold 370 Moderna shares in Q2 2026, an estimated $19.1K.
  • Moderna made up 0.03% of SBI Securities's portfolio in Q2 2026, its #266 holding.
  • SBI Securities first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.